Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 5Phase 1/2 2Phase NA 1Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 14Lymphoma, Large B-Cell, Diffuse 10Glioblastoma 8Astrocytoma 6Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Lymphoma, Follicular 5Lymphoma, Large-Cell, Immunoblastic 4Glioma 4Central Nervous System Neoplasms 4Neoplasms 3Hodgkin Disease 3Gliosarcoma 3Brain Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Lymphoma, Mantle-Cell 2Leukemia 2Breast Neoplasms 2Oligodendroglioma 1Neutropenia 1Neoplasms by Histologic Type 1Lymphoproliferative Disorders 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1Lymphatic Diseases 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1

Interventions

Radiotherapy 12Temozolomide 8Vincristine 6Procarbazine 5Lomustine 4Carboplatin 2Thiotepa 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Peripheral Blood Stem Cell Transplantation 1Methylphenidate 1Methotrexate 1Isotretinoin 1Fentanyl 1Etoposide 1Donepezil 1DNA Methylation 1Cyproheptadine 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Oligodendroglioma × Carmustine × Clear all
NCT01656980 2012-08-03

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma

Shandong Lanjin Pharmaceuticals Co.,Ltd

Phase 3 Unknown
236 enrolled
CNS

Astrocytoma, Glioblastoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡